SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-758650
Filing Date
2016-11-03
Accepted
2016-11-03 14:34:06
Documents
85
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d270155d10q.htm 10-Q 502369
2 EX-31.1 d270155dex311.htm EX-31.1 5978
3 EX-31.2 d270155dex312.htm EX-31.2 5964
4 EX-32.1 d270155dex321.htm EX-32.1 6138
  Complete submission text file 0001193125-16-758650.txt   4716088

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rgen-20160930.xml EX-101.INS 765193
6 XBRL TAXONOMY EXTENSION SCHEMA rgen-20160930.xsd EX-101.SCH 53143
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgen-20160930_cal.xml EX-101.CAL 82774
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgen-20160930_def.xml EX-101.DEF 403332
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgen-20160930_lab.xml EX-101.LAB 487530
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgen-20160930_pre.xml EX-101.PRE 471791
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-14656 | Film No.: 161971173
SIC: 2836 Biological Products, (No Diagnostic Substances)